Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 13/20 | 1.00 |
| ▸ | CA2 | P00918 | 6/20 | 1.00 |
| ▸ | CA9 | Q16790 | 6/20 | 1.00 |
| ▸ | CA1 | P00915 | 3/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.75 |
| ▸ | ESR1 | P03372 | 2/20 | 0.67 |
| ▸ | CA4 | P22748 | 1/20 | 0.67 |
| ▸ | CA6 | P23280 | 1/20 | 0.67 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5168626 | 1.00 | STS (1.00) | STSCA2CA9CA1ABCC4 | |
| SCHEMBL12192152 | 1.00 | STS (1.00) | STSCA2CA9CA1ABCC4 | |
| SCHEMBL5168738 | 0.92 | STS (0.85) | STSCA2CA9CA1ABCC4 | |
| SCHEMBL12216758 | 0.91 | STS (0.84) | STSCA2CA9CA1ABCC4 | |
| SCHEMBL628173 | 0.89 | STS (1.00) | STSCA2CA9CA1ABCC4 | |
| SCHEMBL12609016 | 0.89 | STS (0.81) | STSCA2CA9CA1ABCC4 | |
| SCHEMBL5165243 | 0.89 | STS (1.00) | STSCA2CA9CA1ABCC4 | |
| SCHEMBL12192149 | 0.88 | STS (0.78) | STSCA2CA9CA1ABCC4 | |
| Estradiol Disulfate SCHEMBL6438712 | 0.88 | STS (0.78) | STSCA2CA9CA1ABCC4 | |
| Estradiol Disulfate SCHEMBL6409238 | 0.88 | STS (0.78) | STSCA2CA9CA1ABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1772462-A2 | Steroid sulfamates, method for the production and use thereof | Sterix Limited (GB) | 2007-04-11 | — | — | EP | claimed |
| WO-2001045678-A2 | MEDICAMENT, A METHOD FOR ITS PRODUCTION AND THE USE THEREOF | ID PHARMA GMBH (DE) | 2001-06-28 | — | — | WO | claimed |
| EP-1772462-A2 | Steroid sulfamates, method for the production and use thereof | Sterix Limited (GB) | 2007-04-11 | — | — | EP | disclosed |
| EP-0970104-B1 | STEROID SULFAMATES, METHOD FOR THE PRODUCTION AND USE THEREOF | STERIX LTD (GB) | 2006-11-22 | — | — | EP | disclosed |
| US-6339079-B1 | FOR THERAPY AND DIAGNOSIS OF ESTROGEN-DEPENDENT TUMORS | ID PHARMA GMBH (DE) | 2002-01-15 | — | — | US | disclosed |
| WO-2001045678-A2 | MEDICAMENT, A METHOD FOR ITS PRODUCTION AND THE USE THEREOF | ID PHARMA GMBH (DE) | 2001-06-28 | — | — | WO | disclosed |
| US-6080735-A | SUITABLE FOR HORMONAL CONTRACEPTION AND CLIMACTERIC HORMONE REPLACEMENT THERAPY (HRT) AS WELL AS FOR TREATMENT OF GYNECOLOGICAL AND ANDROLOGICAL DISEASES | JENAPHARM GMBH & CO. KG (DE) | 2000-06-27 | — | — | US | disclosed |